Grifols (GIFOF) EPS (Basic) Growth (5y) (2015 - 2020)
Grifols (GIFOF) EPS (Basic) Growth (5y) (2015 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 94,953,942.17 Bn | 94,953,937.20 Bn | 7.76 Bn |
| 2 | Eli Lilly | 1,003.63 Bn | 998.35 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 565.11 Bn | 543.05 Bn | 15.96 Bn |
| 4 | AbbVie | 394.09 Bn | 384.74 Bn | 10.78 Bn |
| 5 | Merck | 284.43 Bn | 278.78 Bn | 12.09 Bn |
| 6 | Amgen | 187.76 Bn | 175.72 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 158.03 Bn | 150.31 Bn | 5.52 Bn |
| 8 | Pfizer | 147.82 Bn | 135.05 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 113.94 Bn | 103.49 Bn | 8.07 Bn |
| 10 | Grifols | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | -62.52% |
| Jun 30, 2018 | -61.34% |
| Mar 31, 2018 | -64.89% |
| Dec 31, 2017 | -74.26% |
| Jun 30, 2017 | 27.32% |
| Dec 31, 2016 | -90.43% |
| Sep 30, 2016 | 38.26% |
| Jun 30, 2016 | 37.31% |
| Dec 31, 2015 | -91.10% |
| Sep 30, 2015 | 28.97% |